[RDF data]
Aldesleukin
Resource URI: http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugs/DB00041
Home | All drugs
Property	Value
drugbank:affectedOrganism	Humans and other mammals
drugbank:ahfsCode	10:00.00
drugbank:atcCode	L03AC01
drugbank:brandName	Proleukin
drugbank:brandName	Proleukin (Chiron Corp)
drugbank:casRegistryNumber	<http://bio2rdf.org/cas:85898-30-2>
drugbank:chemicalFormula	C690H1115N177O202S6
drugbank:chemicalIupacName	Human interleukin 2 (modified)
drugbank:chemicalStructure	>DB00041 sequence PTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRMLTFKFYMPKKATELKHLQCLEE ELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSETTFMCEYADETATIVEFLNRW ITFAQSIISTLT
drugbank:contraindicationInsert	<http://129.128.185.122/drugbank2/drugs/DB00041/inserts/853/full>
drugbank:creationDate	2005-06-13 13:24:05 UTC
drugbank:description	Proleukin, a lymphokine, is produced by recombinant DNA technology using a genetically engineered E. coli strain containing an analog of the human interleukin-2 gene. Genetic engineering techniques were used to modify the human IL-2 gene, and the resulting expression clone encodes a modified human interleukin-2. This recombinant form differs from native interleukin-2 in the following ways:  a) proleukin is not glycosylated because it is derived from E. coli ; b) the molecule has no N-terminal alanine; the codon for this amino acid was deleted during the genetic engineering procedure; c) the molecule has serine substituted for cysteine at amino acid position 125.
drugbank:dosageForm	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/dosageforms/powderForSolutionIntravenous>
drugbank:dpdDrugIdNumber	02130181
drugbank:drugCategory	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugcategory/antineoplasticAgents>
drugbank:drugIdNumberPage	<http://205.193.93.51/dpdonline/searchRequest.do?din=02130181>
drugbank:drugType	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugtype/approved>
drugbank:drugType	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugtype/biotech>
drugbank:drugType	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/drugtype/investigational>
drugbank:experimentalLogpHydrophobicity	-0.192
drugbank:genbankId	M11144
drugbank:genericName	Aldesleukin
drugbank:halfLife	13 min-85 min
drugbank:indication	For treatment of adults with metastatic renal cell carcinoma
drugbank:interactionInsert	<http://129.128.185.122/drugbank2/drugs/DB00041/inserts/1872/full>
rdfs:label	Aldesleukin
drugbank:limsDrugId	41
drugbank:massSpecFile	0
drugbank:mechanismOfAction	Proleukin binds to the IL-2 receptor which leads to heterodimerization of the cytoplasmic domains of the IL-2R beta and gamma(c) chains, activation of the tyrosine kinase Jak3, and phosphorylation of tyrosine residues on the IL-2R beta chain. These events led to the creation of an activated receptor complex, to which various cytoplasmic signaling molecules are recruited and become substrates for regulatory enzymes (especially tyrosine kinases) that are associated with the receptor. These events stimulate growth and differentiation of T cells.
drugbank:molecularWeightAverage	15314.8
foaf:page	<http://dbpedia.org/page/Aldesleukin>
foaf:page	<http://en.wikipedia.org/wiki/Aldesleukin>
foaf:page	<http://www.drugbank.ca/drugs/DB00041>
drugbank:pdbExperimentalId	3INK
drugbank:pharmacology	Used to treat renal cell carcinoma, proleukin induces the enhancement of lymphocyte mitogenesis and stimulation of long-term growth of human interleukin-2 dependent cell lines, the enhancement of lymphocyte cytotoxicity, the induction of killer cell (lymphokine-activated (LAK) and natural (NK)) activity; and the induction of interferon-gamma production. IL-2 is normally produced by the body, secreted by T cells, and stimulates growth and differentiation of T cell response. It can be used in immunotherapy to treat cancer. It enhances the ability of the immune system to kill tumor cells and may interfere with blood flow to the tumor.
drugbank:pharmgkbId	PA448081
drugbank:pkaIsoelectricPoint	7.31
drugbank:possibleDiseaseTarget	<http://wifo5-04.informatik.uni-mannheim.de/diseasome/resource/diseases/1046>
drugbank:possibleDiseaseTarget	<http://wifo5-04.informatik.uni-mannheim.de/diseasome/resource/diseases/1262>
drugbank:possibleDiseaseTarget	<http://wifo5-04.informatik.uni-mannheim.de/diseasome/resource/diseases/1955>
drugbank:possibleDiseaseTarget	<http://wifo5-04.informatik.uni-mannheim.de/diseasome/resource/diseases/2812>
drugbank:possibleDiseaseTarget	<http://wifo5-04.informatik.uni-mannheim.de/diseasome/resource/diseases/3877>
drugbank:possibleDiseaseTarget	<http://wifo5-04.informatik.uni-mannheim.de/diseasome/resource/diseases/615>
drugbank:primaryAccessionNo	DB00041
drugbank:rxlistLink	<http://www.rxlist.com/cgi/generic2/aldesleukin.htm>
owl:sameAs	<http://data.linkedct.org/resource/intervention/15748>
owl:sameAs	<http://data.linkedct.org/resource/intervention/26477>
owl:sameAs	<http://data.linkedct.org/resource/intervention/38351>
owl:sameAs	<http://data.linkedct.org/resource/intervention/39698>
owl:sameAs	<http://data.linkedct.org/resource/intervention/43593>
owl:sameAs	<http://data.linkedct.org/resource/intervention/49477>
owl:sameAs	<http://data.linkedct.org/resource/intervention/51474>
owl:sameAs	<http://data.linkedct.org/resource/intervention/56641>
owl:sameAs	<http://data.linkedct.org/resource/intervention/6961>
owl:sameAs	<http://dbpedia.org/resource/Aldesleukin>
drugbank:secondaryAccessionNumber	biod00082
drugbank:secondaryAccessionNumber	btd00082
drugbank:state	Liquid
drugbank:structure	0
drugbank:swissprotId	<http://bio2rdf.org/uniprot:P60569>
drugbank:swissprotName	IL2_HYLLA
drugbank:swissprotPage	<http://www.uniprot.org/uniprot/P60569>
drugbank:synonym	IL-2
drugbank:synonym	Interleukin-2 precursor
drugbank:synonym	T-cell growth factor
drugbank:synonym	TCGF
drugbank:synonym	aldesleukin
drugbank:target	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/targets/3823>
drugbank:target	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/targets/717>
drugbank:target	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/resource/targets/724>
rdf:type	drugbank:drugs
rdf:type	vocabClass:Offer
drugbank:updateDate	2008-03-19 16:41:04 UTC
The server is configured to display only a limited number of values (limit per property bridge: 50).



Metadata
<http://wifo5-04.informatik.uni-mannheim.de/drugbank/data/drugs/DB00041>  
dc:date	2016-07-06T23:13:45.885Z
prv:containedBy	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/dataset>
void:inDataset	<http://wifo5-04.informatik.uni-mannheim.de/drugbank/dataset>
rdf:type	prv:DataItem
rdf:type	foaf:Document
Generated by D2R Server